Table 1.
Demographic and clinical characteristics for IPD patients and healthy controls.
| Patients |
Controls |
|||
|---|---|---|---|---|
| Mean (SD) | n | Mean (SD) | n | |
| Demographics | ||||
| Females | – | 5 | – | 10 |
| Males | – | 10 | – | 10 |
| Handedness | ||||
| Right | – | 15 | – | 20 |
| Age | 67.2 (7.5) | 15 | 66.4 (7.8) | 20 |
| Years of education | 14.7 (2.7) | 15 | 14.4 (3.0) | 20 |
| Age at onset | 59.3 (7.4) | 15 | – | – |
| Disease duration | 7.9 (2.7) | 15 | – | – |
| Clinical Characteristics | ||||
| UPDRS | ||||
| I (mentation, behavior, and mood) | 2.47 (1.8) | 15 | – | – |
| II (activities of daily living) | 12 (6.11) | 15 | – | – |
| III (motor examination) | 23.3 (12.4) | 15 | – | – |
| Total score | 37.7 (18.8) | 15 | – | – |
| Hoehn and Yahr | 2.0 (0.7) | 15 | – | – |
| 0.5 | – | 1 | – | – |
| 1 | – | 2 | – | – |
| 2 | – | 6 | – | – |
| 2.5 | – | 5 | – | – |
| 3 | – | 1 | – | – |
| Schwab and England | 87.9 (5.8) | 15 | – | – |
| Medication | ||||
| l-Dopa LED | 136.0 (159.3) | 14 | – | – |
| Ago LED | 253.0 (201.2) | 14 | – | – |
| Total LED | 363.0 (260.5) | 15 | – | – |